Clinical Trial Update: Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of SP-103 in adults with moderate to severe acute lower back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• SP-103

Snippet

Sponsor: Scilex Pharmaceuticals, Inc. | Conditions: Moderate to Severe Acute Lower Back Pain | Phase 2 | Status: COMPLETED